| Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma MA Parasramka, S Maji, A Matsuda, IK Yan, T Patel Pharmacology & therapeutics 161, 67-78, 2016 | 210 | 2016 |
| Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma RW Joseph, P Kapur, DJ Serie, JE Eckel‐Passow, M Parasramka, T Ho, ... Cancer 120 (7), 1059-1067, 2014 | 167 | 2014 |
| Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma RW Joseph, P Kapur, DJ Serie, JE Eckel‐Passow, M Parasramka, T Ho, ... Cancer 120 (7), 1059-1067, 2014 | 167 | 2014 |
| Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression RW Joseph, P Kapur, DJ Serie, M Parasramka, TH Ho, JC Cheville, ... The Journal of urology 195 (1), 180-187, 2016 | 160 | 2016 |
| MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals MA Parasramka, E Ho, DE Williams, RH Dashwood Molecular carcinogenesis 51 (3), 213-230, 2012 | 144 | 2012 |
| Extracellular vesicles from bone marrow–derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury H Haga, IK Yan, DA Borrelli, A Matsuda, M Parasramka, N Shukla, ... Liver Transplantation 23 (6), 791-803, 2017 | 129 | 2017 |
| Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells MA Parasramka, SV Gupta Journal of oncology 2012, 2012 | 95 | 2012 |
| BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma M Parasramka, IK Yan, X Wang, P Nguyen, A Matsuda, S Maji, C Foye, ... Molecular cancer 16, 1-12, 2017 | 79 | 2017 |
| Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes TH Ho, DJ Serie, M Parasramka, JC Cheville, BM Bot, W Tan, L Wang, ... Annals of Oncology 28 (3), 604-610, 2017 | 77 | 2017 |
| Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with micro RNA signatures MA Parasramka, S Ali, S Banerjee, T Deryavoush, FH Sarkar, SV Gupta Molecular nutrition & food research 57 (2), 235-248, 2013 | 71 | 2013 |
| Extracellular vesicles in liver diseases S Maji, A Matsuda, IK Yan, M Parasramka, T Patel American Journal of Physiology-Gastrointestinal and Liver Physiology 312 (3 …, 2017 | 68 | 2017 |
| A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis MA Parasramka, WM Dashwood, R Wang, HH Saeed, DE Williams, E Ho, ... Clinical epigenetics 4, 1-10, 2012 | 67 | 2012 |
| Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma TH Ho, P Kapur, RW Joseph, DJ Serie, JE Eckel-Passow, M Parasramka, ... Urologic Oncology: Seminars and Original Investigations 33 (1), 23. e9-23. e14, 2015 | 57 | 2015 |
| Garcinol inhibits cell proliferation and promotes apoptosis in pancreatic adenocarcinoma cells MA Parasramka, SV Gupta Nutrition and cancer 63 (3), 456-465, 2011 | 57 | 2011 |
| Clear cell type A and B molecular subtypes in metastatic clear cell renal cell carcinoma: tumor heterogeneity and aggressiveness DJ Serie, RW Joseph, JC Cheville, TH Ho, M Parasramka, T Hilton, ... European urology 71 (6), 979-985, 2017 | 55 | 2017 |
| Micro RNA profiling of carcinogen‐induced rat colon tumors and the influence of dietary spinach MA Parasramka, WM Dashwood, R Wang, A Abdelli, GS Bailey, ... Molecular nutrition & food research 56 (8), 1259-1269, 2012 | 48 | 2012 |
| In vitro toxicology studies of extracellular vesicles S Maji, IK Yan, M Parasramka, S Mohankumar, A Matsuda, T Patel Journal of Applied Toxicology 37 (3), 310-318, 2017 | 45 | 2017 |
| Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma RW Joseph, M Parasramka, JE Eckel-Passow, D Serie, K Wu, L Jiang, ... Cancer immunology research 1 (6), 378-385, 2013 | 43 | 2013 |
| Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma AS Parker, JE Eckel-Passow, D Serie, T Hilton, M Parasramka, ... European urology 66 (5), 929-935, 2014 | 40 | 2014 |
| Association between programmed death-ligand 1 expression and the vascular endothelial growth factor pathway in angiosarcoma SP Bagaria, Z Gatalica, T Maney, D Serie, M Parasramka, S Attia, ... Frontiers in Oncology 8, 71, 2018 | 25 | 2018 |
